Items Tagged ‘leiomyosarcoma’

November 7th, 2016

Chemotherapy Before Surgery Improves Treatment of Sarcoma

By

For patients with localized soft-tissue sarcoma of the trunk or extremities who are high risk for relapse, the use of anthracycline plus ifosfamide chemotherapy prior to surgery appears to improve survival. Chemotherapy administered before surgery is called neoadjuvant therapy and has not previously been demonstrated to improve outcomes in soft tissue sarcoma (STS). Soft tissue […]

View full entry

Tags: anthracycline, dacarbazine, epirubicin, for undifferentiated pleomorphic sarcoma, gemcitabine, ifosfamide, leiomyosarcoma, malignant peripheral nerve sheath tumors, neoadjuvant therapy, News, Sarcoma, soft tissue sarcoma


October 20th, 2015

Yondelis® Bests Standard Therapy in Liposarcoma and Leiomyosarcoma

By

The chemotherapy agent, Yondelis® (trabectedine), improves outcomes compared to the standard agent, DTIC (dacarbazine), in patients with advanced liposarcoma or leiomyosarcoma that has recurred or progressed following prior therapies. These results were recently published as a “rapid communication” in the Journal of Clinical Oncology. Liposarcoma and leiomyosarcoma are both types of soft-tissue sarcomas.  Soft tissue […]

View full entry

Tags: dacarbazine, DTIC, leiomyosarcoma, liposarcoma, News, Sarcoma, Soft Tissue Sarcomas, trabectedine, yondelis


June 11th, 2015

Longer Overall Survival for Patients with Soft Tissue Sarcoma Treated with Halaven®

By

Halaven® (eribulin) may extend overall survival in patients with previously treated, advanced soft tissue sarcoma (STS). These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the Journal of Clinical Oncology.[1] Soft tissue sarcomas are cancers that affect the connective and supportive […]

View full entry

Tags: ADI, adipocytic sarcoma, Halaven, leiomyosarcoma, LMS, News, Sarcoma, soft tissue sarcoma, Soft Tissue Sarcomas, STS